ITC Begins Section 337 Investigation on Blood Cholesterol Testing Strips
The International Trade Commission began a Section 337 investigation into allegations that imports of blood cholesterol testing strips by ACON infringe patents held by Polymer Technology Systems, the ITC said in a press release. In a complaint filed April 30 (see 1805070013), PTS said the Mission Cholesterol Monitoring System imported and sold by ACON Laboratories and its affiliate ACON Biotech (Hangzhou) Co., Ltd. infringe patents associated with PTS’s CardioChek cholesterol test strip system. The accused products come in under Harmonized Tariff Schedule subheadings 9027.80.4530 and 9027.50.4015. The ITC will consider whether to issue a limited exclusion order and cease and desist orders banning importation and sale of infringing merchandise by the following respondents:
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
- ACON Laboratories, Inc., of San Diego, California
- ACON Biotech (Hangzhou) Co., Ltd., of Hangzhou Zhejiang, China.
(ITC Inv. No. 337-TA-1116)